Canada - World Health Organization Regional Office for Europe
Canada - World Health Organization Regional Office for Europe
Canada - World Health Organization Regional Office for Europe
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
34<br />
<strong>Health</strong> systems in transition <strong>Canada</strong><br />
governance and accountability. They have also established more arm’s length<br />
and special purpose intergovernmental bodies (illustrated at the bottom of<br />
Fig. 2.1) to support work in priority areas determined by F/P/T governments. In<br />
most cases, the federal government provides a significant share of the funding.<br />
The Canadian Agency <strong>for</strong> Drugs and Technologies in <strong>Health</strong> (CADTH) was<br />
first established under the name of the Canadian Coordinating <strong>Office</strong> <strong>for</strong> <strong>Health</strong><br />
Technology Assessment. Its mandate is to encourage the appropriate use of health<br />
technology by influencing decision-makers through the collection, creation<br />
and dissemination of HTA of new medical technologies and pharmaceutical<br />
therapies. Given the existence of provincial HTA organizations, this also means<br />
that CADTH coordinates the dissemination of existing studies throughout<br />
the country as well as original HTAs in areas not covered by the provincial<br />
agencies. CADTH is funded by <strong>Health</strong> <strong>Canada</strong> and by the provinces and<br />
territories (in proportion to population) with the exception of Quebec. In 2003,<br />
CADTH launched the Common Drug Review (CDR), a single, pan-Canadian<br />
process <strong>for</strong> reviewing new drugs and making <strong>for</strong>mulary recommendations to<br />
the government members of CADTH (Menon & Stafinski, 2009).<br />
Established in 1994, the Canadian Institute <strong>for</strong> <strong>Health</strong> In<strong>for</strong>mation<br />
(CIHI) was a response to the desire of F/P/T governments <strong>for</strong> a nationally<br />
coordinated approach to gathering and analysing their respective financial<br />
and administrative data. Its core functions include identifying and defining<br />
national health indicators and frameworks, coordinating the development and<br />
maintenance of pan-Canadian data standards, developing and managing F/P/T<br />
health databases and registries, and disseminating health data through research<br />
reports. By 2011, CIHI was maintaining a total of 27 databases and clinical<br />
registries, including the National <strong>Health</strong> Expenditure Database, the National<br />
Physician Database, the Hospital Morbidity Database, the Discharge Abstract<br />
Database and the National Prescription Drug Utilization and In<strong>for</strong>mation<br />
Systems Database. Approximately 80% of CIHI’s funding comes from <strong>Health</strong><br />
<strong>Canada</strong> and the remaining funds from provincial governments. CIHI also has<br />
an ongoing partnership with Statistics <strong>Canada</strong>, as well as a strong advisory<br />
relationship with the Conference of F/P/T Deputy Ministers of <strong>Health</strong> through<br />
its 16-member board of directors.<br />
<strong>Canada</strong> <strong>Health</strong> Infoway is a product of the 2000 First Ministers’ Accord on<br />
<strong>Health</strong> Care Renewal and the priority assigned by F/P/T ministries of health to<br />
the development of electronic health records (EHRs) using compatible standards.<br />
Since its creation in 2001, Infoway has been allocated C$2.1 billion in federal<br />
government funding to work with provincial and territorial governments to